Safety of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2-I) During the Month of Ramadan in Muslim Patients with Type 2 Diabetes

OBJECTIVES: Sodium-glucose cotransporter 2 inhibitors (SGLT2-I) are a new class of antidiabetic drugs that might increase the risk of dehydration and hypoglycemia, particularly during the month of Ramadan in which Muslims abstain from eating and drinking for 14–16 hours daily. We aimed to provide re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oman Med J
Main Authors: Bashier, Alaaeldin, Khalifa, Azza Abdulaziz, Abdelgadir, Elamin Ibrahim, Al Saeed, Maryam Ahmad, Al Qaysi, Amina Adil, Bayati, Murad Burhan Ali, Alemadi, Budoor, Bachet, Fawzi, Alawadi, Fatheya, Hassanein, Mohammed
Formato: Artigo
Idioma:Inglês
Publicado em: OMJ 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889836/
https://ncbi.nlm.nih.gov/pubmed/29657678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5001/omj.2018.21
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados